Advancing drug candidates with the goal of delivering transformative medicines for patients.
We are advancing a pipeline of novel medicines to potentially treat a wide variety of indications, including autoimmune and inflammatory diseases, dermatological diseases, and neurological disorders, while also generating a library of chemical matter directed against elusive targets for future pipeline and business development needs.